Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson’s disease
Nasia Antoniou, Kanella Prodromidou, Georgia Kouroupi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders
Guangming Zhang, Huayuan Wei, Anliu Zhao, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Systematic identification of structure-specific protein–protein interactions
Aleš Holfeld, Dina Schuster, Fabian Sesterhenn, et al.
Molecular Systems Biology (2024) Vol. 20, Iss. 6, pp. 651-675
Open Access | Times Cited: 11
Midbrain organoids for Parkinson's disease (PD) - A powerful tool to understand the disease pathogenesis
Harysh Winster Suresh Babu, Sindduja Muthu Kumar, Harsimrat Kaur, et al.
Life Sciences (2024) Vol. 345, pp. 122610-122610
Closed Access | Times Cited: 10
A drug screening platform for protein expression levels in neurological disorders
Farida Emran, Ibrahim Kays, Chiu‐An Lo, et al.
BioTechniques (2025), pp. 1-12
Open Access
Phenotypic drug discovery
Sonja Sievers, Herbert Waldmann, Slava Ziegler
Elsevier eBooks (2025)
Closed Access
A comprehensive update on the application of high-throughput fluorescence imaging for novel drug discovery
Michael Ronzetti, Anton Simeonov
Expert Opinion on Drug Discovery (2025)
Closed Access
Rapid and Robust Multi-Phenotypic Assay System for ALS Using Human iPS Cells with Mutations in Causative Genes
Tosho Kondo, Ihori Ebinuma, Hirotaka Tanaka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6987-6987
Open Access | Times Cited: 8
Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases
Dorit Trudler, Swagata Ghatak, Stuart A. Lipton
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8196-8196
Open Access | Times Cited: 17
Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson’s Disease
Jennifer Sally Samson, Anuradha Ramesh, Venkatachalam Deepa Parvathi
Neuroscience (2024) Vol. 546, pp. 1-19
Closed Access | Times Cited: 2
ATM-mediated co-chaperone DNAJB11 phosphorylation facilitates α-synuclein folding upon DNA double-stranded breaks
Huan-Yun Chen, Chia-Yu Liao, Hsun Li, et al.
Deleted Journal (2024) Vol. 1, Iss. 2
Open Access | Times Cited: 2
AZD5438 a GSK-3a/b and CDK inhibitor is antiapoptotic modulates mitochondrial activity and protects human neurons from mitochondrial toxins
Gongyu Shi, Helen L. Scott, Nur Izzah Farhana Mohamad Azhar, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Proteome dynamics in iPSC-derived human dopaminergic neurons
Claudia Cavarischia-Rega, Karan Sharma, Julia C. Fitzgerald, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 10, pp. 100838-100838
Open Access | Times Cited: 1
Recent Advances in High-Content Imaging and Analysis in iPSC-Based Modelling of Neurodegenerative Diseases
Giovanna Menduti, Marina Boido
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14689-14689
Open Access | Times Cited: 3
Proteomic Changes in the Hippocampus after Repeated Explosive-Driven Blasts
Diego Iacono, Kathleen Hatch, Erin K. Murphy, et al.
Journal of Proteome Research (2023) Vol. 23, Iss. 1, pp. 397-408
Open Access | Times Cited: 2
Induced-pluripotent stem cells and neuroproteomics as tools for studying neurodegeneration
Caroline Brandão‐Teles, Giuliana S. Zuccoli, Talita Aparecida de Moraes Vrechi, et al.
Biochemical Society Transactions (2024) Vol. 52, Iss. 1, pp. 163-176
Closed Access
Proteomic changes in the hippocampus of large mammals after total-body low dose radiation
Diego Iacono, Kathleen Hatch, Erin K. Murphy, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0296903-e0296903
Open Access
Human Induced Pluripotent Stem Cell–Derived Neuronal Cell Cultures in Drug Discovery and Development
Olaf Hans-Ulrich Schroeder, Luise Schultz, Anne‐Marie Knospe, et al.
Springer eBooks (2024), pp. 1-17
Closed Access
ERO1A inhibition mitigates neuronal ER stress and ameliorates UBQLN2ALS phenotypes in Drosophila melanogaster
Ranchana Yeewa, Apiwat Sangphukieo, Phatcharida Jantaree, et al.
Progress in Neurobiology (2024) Vol. 242, pp. 102674-102674
Closed Access
Human Induced Pluripotent Stem Cell–Derived Neuronal Cell Cultures in Drug Discovery and Development
Olaf Hans-Ulrich Schroeder, Luise Schultz, Anne‐Marie Knospe, et al.
Springer eBooks (2024), pp. 1063-1079
Closed Access
Proteostasis dysregulation in p.A53T-α-Synuclein iPSC-derived astrocytes exacerbates neurodegeneration in a Parkinson's disease model with Lewy-like pathology
Christina Paschou, Olympia Apokotou, Αναστάσιος Κόλλιας, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pluripotent Stem Cell-derived Dopaminergic Neurons for Studying Developmental Neurotoxicity
Anna Kreutz, Guang Hu, Erik J. Tokar
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 7, pp. 2120-2130
Open Access
Orals

Glia (2023) Vol. 71, Iss. S1
Open Access
Variation in Exon 29 of the NOS1 Gene Does Not Contribute to Parkinson’s Disease in the North Karnataka Population
Rudragouda Bulagouda, Smita Hegde, Rajat Hegde, et al.
Cureus (2023)
Open Access
Page 1

Scroll to top